Latest news with #AnthemBiosciencesIPO
Indian Express
a day ago
- Business
- Indian Express
IPO Listing on July 21: Anthem Biosciences to debut on NSE, BSE
IPO Listing on July 21: Anthem Biosciences Limited will make its debut on NSE (National Stock Exchange) and BSE (Bombay Stock Exchange) on Monday, July 21. Anthem Biosciences IPO allotment finalised last week. The three-day subscription for Anthem Biosciences IPO was opened on July 14 (Monday) and closed on July 16 (Wednesday). On the closing day of the bidding, the initial public offer of Anthem Biosciences Ltd subscribed 63.86 times. The initial share sale received bids for 2,81,44,34,740 shares against 4,40,70,682 shares on offer, according to NSE data. The portion for qualified institutional buyers (QIBs) fetched a whopping 182.65 times subscription. The non-institutional investors part got subscribed 42.35 times, and retail individual investors (RIIs) received a 5.64 times subscription. Anthem Biosciences IPO has fixed the price band at Rs 540 to Rs 570 per equity share. KFin Technologies Limited is the registrar of Anthem Biosciences IPO. The face value and tick size of Anthem Biosciences IPO is Rs 2 and Re 1, respectively. Anthem Biosciences Limited's shares are proposed to be listed on NSE, and BSE. The listing will likely take place on July 21. JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead managers for the Anthem Biosciences IPO. HDFC Bank Limited and ICICI Bank Limited are the sponsor banks for the Anthem Biosciences IPO. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It also manufactures and sells complex, specialised fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. (With inputs from PTI)
India Today
5 days ago
- Business
- India Today
Anthem Biosciences IPO: Allotment status live. GMP, listing details here
The allotment of shares for the initial public offering (IPO) of Anthem Biosciences Limited is set to be finalised on Thursday, July 17, Biosciences IPO, which opened for subscription on July 14 and closed on July 16, received an overwhelming response from investors across public issue, worth Rs 3,395 crore, was subscribed 67.42 times in total. This includes 5.98 times in the retail category, 192.80 times in the qualified institutional buyers (QIB) category, and 44.70 times in the non-institutional investors (NII) category by the end of Day strong demand reflects high investor interest in the company, even though the Anthem Biosciences IPO was entirely an offer for sale (OFS) of 5.96 crore equity shares by existing Biosciences itself will not receive any direct funds from the offer. The price band for the issue was fixed at Rs 570 per TO CHECK ALLOTMENT STATUS ONLINEInvestors who applied for the Anthem Biosciences IPO can check their allotment status online through two platforms: the BSE website and the website of the IPO registrar, KFin BSE Website:Visit the official BSE allotment status "Issue Type", select "Equity".From the "Issue Name" dropdown, choose "Anthem Biosciences Limited".Enter your application your PAN the captcha and click "Search".Via KFin Technologies Website:Visit the KFin Technologies IPO status "Anthem Biosciences Limited" from the your preferred method to search: Application Number, Demat Account Number or your application type: ASBA or in the required details and complete the "Submit" to view your allotment MARKET PREMIUM (GMP) TRENDThe grey market premium (GMP) for Anthem Biosciences IPO has been steadily climbing but saw a slight dip a day before the of July 17 at 7:29 AM, the latest GMP stands at Rs 144. Given the upper price band of Rs 570, the estimated listing price comes to around Rs 714. This implies a potential listing gain of about 25.26% per share based on the current shares of Anthem Biosciences are expected to list on both the BSE and NSE on Monday, July 21, 2025. Given the strong oversubscription and steady grey market activity, investors are closely watching the listing performance.- Ends advertisement
Indian Express
5 days ago
- Business
- Indian Express
Anthem Biosciences IPO allotment on July 17: Know how to check status online via PAN
Anthem Biosciences IPO: Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the investors will now be on the finalisation of the allotment of shares. The Anthem Biosciences IPO allotment will take place tomorrow i.e., July 17. The Anthem Biosciences IPO subscription was opened on July 14 (Monday) and closed on July 16 (Wednesday). On Wednesday, the initial share sale received bids for 2,81,42,36,230 shares, as against 4,40,70,682 shares on offer, according to NSE data. The category for non-institutional investors fetched 42.35 times subscription, while the quota for retail individual investors (RIIs) got subscribed 5.63 times. Qualified institutional buyers (QIBs) part received 182.65 times subscription. Anthem Biosciences IPO has fixed the price band at Rs 540 to Rs 570 per equity share. According to the details available, the Anthem Biosciences IPO is slated to be finalised on July 17. The allotment status of Anthem Biosciences IPO will be released online on the official website of the Registrar – KFin Technologies Limited. Additionally, the allotment status will also be made available on the official websites of the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). – – –
